Overview
Christopher Cann is an Oncologist practicing medicine in Philadelphia, Pennsylvania.
His clinical expertise encompasses Colorectal Cancer, Melanoma, Small Cell Lung Cancer (SCLC), and Agranulocytosis.
Dr. Cann is board certified in American Board Of Internal Medicine - Internal Medicine, American Board Of Internal Medicine - Hematology, and American Board Of Internal Medicine - Medical Oncology. He is actively involved in clinical research, co-authoring 22 peer reviewed articles.
Specialties
Board Certifications
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- HMO
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- EPO
- HMO
- PPO
- EPO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- MANAGED MEDICAID PLAN
- EPO
- HMO
- POS
- PPO
- EPO
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
333 Cottman Avenue, Philadelphia, PA 19111
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Fox Chase Cancer Center
Hossein Borghaei is an Oncologist practicing medicine in Philadelphia, Pennsylvania. Dr. Borghaei is highly rated in 17 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and EGFR Positive Lung Cancer. Dr. Borghaei is board certified in American Board Of Internal Medicine - Medical Oncology.
Fox Chase Cancer Center
Daniel Geynisman is an Oncologist practicing medicine in Philadelphia, Pennsylvania. Dr. Geynisman is highly rated in 18 conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Muscle Invasive Bladder Cancer, Bladder Cancer, Nephrectomy, and Orchiectomy. Dr. Geynisman is board certified in American Board Of Internal Medicine - Medical Oncology.
Fox Chase Cancer Center
Elizabeth Plimack is an Oncologist practicing medicine in Philadelphia, Pennsylvania. Dr. Plimack is highly rated in 15 conditions, according to our data. Her clinical expertise encompasses Renal Cell Carcinoma (RCC), Muscle Invasive Bladder Cancer, Bladder Cancer, Nephrectomy, and Orchiectomy. Dr. Plimack is board certified in American Board Of Internal Medicine - Medical Oncology.
Frequently Asked Questions about Dr. Christopher G. Cann
How do I make an appointment with Dr. Christopher G. Cann?
You can book an appointment with Dr. Christopher G. Cann by calling their office at 888-369-2427. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Christopher G. Cann a top-rated expert for Colorectal Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Christopher G. Cann is classified as an Experienced expert for Colorectal Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Christopher G. Cann specialize in?
While Dr. Christopher G. Cann is a Oncology, they have specific expertise in Colorectal Cancer, Melanoma, and Small Cell Lung Cancer (SCLC). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.
Does Dr. Christopher G. Cann participate in research or clinical trials?
Yes. Dr. Christopher G. Cann has published 22 articles and abstracts on conditions like Colorectal Cancer. You can view a list of Dr. Christopher G. Cann's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Christopher G. Cann accept my insurance?
Dr. Christopher G. Cann accepts most major insurance plans, including Aetna and Blue Cross Blue Shield. We recommend calling the office directly at 888-369-2427 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- AgranulocytosisDr. Cann isExperienced. Learn about Agranulocytosis.
- Anal CancerDr. Cann isExperienced. Learn about Anal Cancer.
- Colorectal CancerDr. Cann isExperienced. Learn about Colorectal Cancer.
- MelanomaDr. Cann isExperienced. Learn about Melanoma.
- Pancreatic CancerDr. Cann isExperienced. Learn about Pancreatic Cancer.
- Small Cell Lung Cancer (SCLC)Dr. Cann isExperienced. Learn about Small Cell Lung Cancer (SCLC).